Search results


Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data
You searched for:
Results: 42
1

Neonatology

NEONATOLOGY Normally, delivery takes place between the 37th and the 42nd week of gestation. By that time, the foetus is fully formed and developed enough to be able to adapt to extra-uterine life. However, in some cases delivery may occur before the 37th week of gestation. In that case, the...
2

Transplantology

Transplantology – transplantation of organs.   Transplantation of an organ, such as a kidney or a liver, is a life-saving modern treatment of patients whose organs do not function properly for some reason. The effectiveness and safety of organ transplantation is well...
3

Rare diseases

The term rare applies to those diseases affecting a limited number of people with a prevalence below a given cut-off point, which is codified by the legislation of each individual country. The EU sets this threshold at 0.05% of the population, i.e. one case for every 2,000 inhabitants (in the US a...
4

Respiratory

Chiesi Farmaceutici is fully committed to the care and improvement of the quality of life of people suffering from respiratory diseases including asthma and COPD (Chronic Obstructive Pulmonary Disease). Asthma and COPD are characterised by a reduction in the respiratory flow although they are...
5

Adverse reactions

Report adverse drug reaction Adverse drug reaction is any adverse and unintended effect resulting from a medication.   If you want to report an adverse reaction which occurred when using Chiesi Group drugs, please: print the Adverse Drug Reaction Reporting Form, fill in the minimum...
6

About us

Chiesi Group, one of the world’s leading producers of modern and innovative medical solutions, focuses on several therapeutic areas, including primarily respiratory diseases specialising in the treatment of asthma, cardiovascular diseases, neonatology, musculoskeletal disorders,...
7

History

-
8

Mission and Values

Our aim is to be recognised as a research-focused international Group, able to develop and commercialise innovative pharmaceutical solutions to improve the quality of human life. We wish to maintain a high quality entrepreneurial team characterised by self-confidence and a collaborative...
9

Management

-
10

Annual report

-
11

Research and Development

 Innovation is the driving force behind every technologically advanced industry, but for the pharmaceutical industry it plays a vital role since it concerns the health and quality of life of people. For Chiesi, Research and Development are a true human and technological asset and, together...
12

Therapeutic areas

-
13

Products

-
14

Business responsibility

As a member of the Employers’ Association of Innovative Pharmaceutical Companies INFARMA, CHIESI POLAND is a signatory of:   Code of Good Manufacturing Practice for Pharmaceutical Industry, which sets standards for activities in: promotion and advertisement of medicinal...
15

Ethics

In order to contribute to common good, ethical behaviour is a fundamental part of CHIESI POLAND’s business activity and expression of its responsibility towards the partners it works with, as well as people who make up the company. Every day, all employees are guided in their actions by...
16

Transparency

Code of Transparency   Cooperation between medical professionals and healthcare organizations has been a driving force in patient care and the development of innovative medicine for many years. Medical professionals and the affiliated organizations provide the pharmaceutical industry...
17

Chiesi Foundation

Founded in 2005, the Chiesi Foundation Onlus is a no-profit organisation which seeks to capitalise on Chiesi’s legacy of knowledge in order to promote health and alleviate the suffering of patients affected by chronic obstructive respiratory diseases, rare diseases and neonatal diseases. The...
18

Patient organizations support

  By providing patients with modern solutions out of concern for their health, Chiesi Group also supports local activities for education and preventive healthcare carried out by patient organizations and other healthcare stakeholders. Cooperation with patient organizations implies total...
19

Sitemap

-
20

Career

JOB OFFERS:   Information about current recruitment processes are published below and on the: www.pracuj.pl job advertising...
21

Cookies

For your convenience, the and www.chiesi.pl webpage, hereinafter referred to as the website, uses cookies and similar technologies, in order to adapt the website to user needs, and for statistical purposes. Cookies are small text files sent by the website visited by the Internet user to their...
22

Contacts

VAT: 527-24-56-136 Trade Register No: 0000223692 Share Capital: 5.000.000,00 zl Court Designation: Regional Court for the City of Warsaw in Warsaw, XII Business Department of the National Court Register
23

News

-
24

Search result

-
25

Term of use

-
26

Registration

-
27

September 12 WE ACT DAY! - We Actively Care for Tomorrow

We do not need to be convinced how important it is to ensure favorable living conditions for the present and future generations and to implement the right to use environmental resources and preserve its value. We hear in the media about the importance of an ecological approach, about non-invasive...
28

CORPORATE SOCIAL RESPONSIBILITY: COMMUNITY DAY CENTER OF THE CHILDREN'S FRIENDS SOCIETY, UL. GROCHOWSKA 259A IN WARSAW - 10 AUGUST 2018

This year, we have been involved in the voluntary work of Chiesi Poland for the third time. Our activities are in line with the extensive charity work of the entire Chiesi Group. Let me remind you that our MISSION is to implement among Chiesi Poland employees the idea of sharing their time and...
29

REDUCTION OF CARBON DIOXIDE EMISSION

Chiesi Poland Sp. z o.o. as a socially responsible company and in accordance with the policy of sustainable development, pay special attention to care for the environment. As a part of the Chiesi Group, we responded to the global challenge and reduce carbon dioxide emissions.  Knowing that...
30

THE FIRST CHIESI SMILE CONFERENCE

On 9th June 2018 the THE FIRST CHIESI SMILE CONFERENCE was held in Warsaw. There was a lot of fun, joy and laughter – the perfect mix! On Saturday we’ve come to our office accompanied by a quite impressive delegation of young generation. Attractions and surprises were waiting for us...
31

ECOLOGY

Eurocentrum Office Complex is a green, user-friendly and eco-friendly building, which obtained American LEED CS precertification on the highest PLATINIUM level. (The Leadership in Energy & Environmental Design).   Obtaining such certificate requires substantial involvement during both...
32

Bramitob®

300 mg /4 ml, nebulizer solution   Report adverse drug reaction.    If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's...
33

Budiair®

200 micrograms /metered dose, inhalation aerosol, solution   Report adverse drug reaction.    If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not...
34

Budiair® (Jet)

200 micrograms / metered dose, inhalation aerosol, solutionpackage with Jet inhalation chamber   Report adverse drug reaction.    If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form...
35

Curosurf®

80 mg /ml, suspension for intratracheal and bronchoalveolar administrationFraction of phospholipids from the lungs of the pig   Report adverse drug reaction.    If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and...
36

Envarsus®

Envarsus 0.75 mg prolonged-release tabletsEnvarsus 1 mg prolonged-release tabletsEnvarsus 4 mg prolonged-release tablets   Report adverse drug reaction.    If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and can not...
37

Flamexin®

20 mg, tablets   Report adverse drug reaction.    If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which the...
38

Fostex®

(100 micrograms + 6 micrograms)/dose, inhalation spray, solutionThe drug is intended for use in adults.   Report adverse drug reaction.    If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and can not be considered as...
39

Holoclar®

79,000 - 316,000 cells / cm2, live replacement tissue   Report adverse drug reaction.    If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not...
40

Peyona®

20 mg/ml, solution for infusion and oral solution   Report adverse drug reaction.    If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a...
41

Atimos®

12 micrograms / metered dose, inhalation aerosol, solution   Therapeutic area: Respiratory   Report adverse drug reaction.      If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and can not be considered...
42

Trimbow®

87 micrograms + 5 micrograms + 9 micrograms, inhalation spray, solution   Report adverse drug reaction.    If you are a doctor please login .... Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical...